Cim Investment Management Inc Alx Oncology Holdings Inc Transaction History

Cim Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $88,110 - $162,088	-10,706 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$13.65 - $22.06 $103,071 - $166,575	7,551 Added 239.33%	10,706 $181,000
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $165,669 - $255,271	3,155 New	3,155 $233,000
Q2 2021 Aug 13, 2021	SELL	$52.2 - $75.23 $164,691 - $237,350	-3,155 Closed	0 $0
Q1 2021 May 20, 2021	BUY	$62.84 - $87.68 $198,260 - $276,630	3,155 New	3,155 $233,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.